CETIRIZINE
Tracking # 20-1020146
$99999.00
There are no ratings for this course
Learn moreCourse overview
CETIRIZINE IS A MEDICATION USED IN THE TREATMENT OF ALLERGIC RHINITIS AND URTICARIA. IT IS A SECOND-GENERATION ANTIHISTAMINE. CETIRIZINE WAS FDA-APPROVED IN THE UNITED STATES AS A PRESCRIPTION-ONLY PRODUCT IN 1995, AND LATER IN 2007, IT GOT APPROVAL AS AN OVER-THE-COUNTER MEDICATION. THIS ACTIVITY REVIEWS THE INDICATIONS, ACTION, AND CONTRAINDICATIONS FOR CETIRIZINE AS A VALUABLE AGENT IN TREATING RHINITIS AND URTICARIA. THIS ACTIVITY WILL HIGHLIGHT THE MECHANISM OF ACTION, ADVERSE EVENT PROFILE, AND OTHER KEY FACTORS (E.G., OFF-LABEL USES, DOSING, PHARMACODYNAMICS, PHARMACOKINETICS, MONITORING, RELEVANT INTERACTIONS) PERTINENT FOR MEMBERS OF THE INTERPROFESSIONAL TEAM IN THE TREATMENT OF PATIENTS USING CETIRIZINE.
Subject areas
This course counts toward the state boards and subject areas below.